ADHERENCE AND PERSISTENCE IN PATIENTS INITIATING TREATMENT WITH INJECTABLE THERAPIES FOR TYPE 2 DIABETES MELLITUS (T2DM) IN SPAIN

被引：1
|
作者：
Sicras-Mainar, A. [1 ]
Navarro, R. [2 ]
Ruiz, L. [3 ]
Morano, R. [3 ]
机构：
[1] Badalona Serv Assistencials, Barcelona, Spain
[2] Hosp Badalona Germans Trias & Pujol, Barcelona, Spain
[3] GlaxoSmithKline, Madrid, Spain
来源：
VALUE IN HEALTH | 2015年 / 18卷 / 07期
关键词：
D O I：
10.1016/j.jval.2015.09.2122
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
PDB82
引用
收藏
页码：A612 / A612
页数：1
相关论文
共 50 条
  • [41] Real-world effectiveness, adherence and persistence among patients with type 2 diabetes mellitus initiating dulaglutide treatment
    Mody, Reema
    Grabner, Michael
    Yu, Maria
    Turner, Ralph
    Kwan, Anita Y. M.
    York, Whitney
    Lando, Laura Fernandez
    [J]. CURRENT MEDICAL RESEARCH AND OPINION, 2018, 34 (06) : 995 - 1003
  • [42] THE ECONOMIC IMPORTANCE OF "METABOLIC MEMORY" IN THE TREATMENT OF TYPE 2 DIABETES MELLITUS (T2DM) IN SWEDEN
    Willis, M.
    He, J.
    Neslusan, C.
    Chicevic, E.
    [J]. VALUE IN HEALTH, 2010, 13 (07) : A291 - A291
  • [43] REAL-WORLD ADHERENCE IN MEDICARE PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM) FOR EXENATIDE QW AND LIRAGLUTIDE QD
    Tarr, A.
    Nguyen, H.
    Dufour, R.
    Bullano, M.
    [J]. VALUE IN HEALTH, 2015, 18 (03) : A57 - A57
  • [44] CHANGES IN DEMOGRAPHIC AND CLINICAL CHARACTERISTICS OF PATIENTS WITH TYPE 2 DIABETES (T2DM) INITIATING SUBCUTANEOUS SEMAGLUTIDE
    Dunn, T. J.
    Swift, C.
    Guesnier, A.
    Noone, J.
    Willey, V
    [J]. VALUE IN HEALTH, 2022, 25 (07) : S321 - S321
  • [45] Effects of Insulin Adherence and Delivery Device on Real World Outcomes Among Patients With Type 2 Diabetes Mellitus (T2DM)
    Ayyagari, Rajeev
    Wei, Wenhui
    Cheng, David
    Pan, Chunshen
    Wu, Eric Q.
    [J]. DIABETES, 2013, 62 : A327 - A327
  • [46] MEDICATION ADHERENCE AND PERSISTANCE IN TYPE 2 DIABETES MELLITUS (T2DM): PATIENTS PERSPECTIVE IN THE SPANISH HEALTH CA RE SYSTEM
    Labrador Barba, E.
    Hernandez Mijares, A.
    Alonso Moreno, F. J.
    Rodriguez de Miguel, M.
    Orera Pena, M. L.
    Aceituno Mata, S.
    Faus Dader, M. J.
    [J]. VALUE IN HEALTH, 2016, 19 (07) : A351 - A351
  • [47] Assessing MicroRNA-375 Levels in Type 2 Diabetes Mellitus (T2DM) Patients and Their First-Degree Relatives with T2DM
    Wu, Xu
    Li, Yashan
    Man, Baohua
    Li, Dexuan
    [J]. DIABETES METABOLIC SYNDROME AND OBESITY-TARGETS AND THERAPY, 2021, 14 : 1445 - 1451
  • [48] Safety and Tolerability of Linagliptin and Metformin in Combination for Patients with Type 2 Diabetes Mellitus (T2DM)
    Ross, Stuart A.
    Haak, Thomas
    Patel, Sanjay
    Thiemann, Sandra
    Schumacher, Helmut
    Meinicke, Thomas
    [J]. DIABETES, 2014, 63 : A277 - A277
  • [49] The agreement of patient-reported versus observed medication adherence in type 2 diabetes mellitus (T2DM)
    Kelly, Katherine
    Grau-Sepulveda, Maria V.
    Goldstein, Benjamin A.
    Spratt, Susan E.
    Wolfley, Anne
    Hatfield, Vicki
    Murphy, Monica
    Jones, Ellen
    Granger, Bradi B.
    [J]. BMJ OPEN DIABETES RESEARCH & CARE, 2016, 4 (01)
  • [50] RESEARCH ON THE INCIDENCE AND COST OF HYPOGLYCEMIA EPISODE IN PATIENTS WITH TYPE 2 DIABETES MELLITUS (T2DM)
    Zheng, Y.
    Wu, J.
    Oesterle, A.
    [J]. VALUE IN HEALTH, 2012, 15 (07) : A504 - A505
12345